Abstract Response Evaluation Criteria in Solid Tumors (RECIST) is the gold standard for
assessment of treatment response in solid tumors. Morphologic change of tumor size …

Response Evaluation Criteria In Solid Tumors (RECIST) is still the predominant criteria base
for assessing tumor burden in oncology clinical trials. Despite several improvements that …

PURPOSE Clinical TNM staging is a key prognostic factor for patients with lung cancer and
is used to inform treatment and monitoring. Computed tomography (CT) plays a central role …

Introduction: Tumor growth rate (TGR), percentage of change in tumor volume/month, has
been previously identified as an early radiological biomarker for treatment monitoring in …

Simple Summary Lung cancer treatment has dramatically evolved in the past decade, but
some pitfalls of image interpretation have been introduced in parallel, such as pseudo …

Objectives: Compare total tumor volume (TTV) response after systemic treatment to
Response Evaluation Criteria in Solid Tumors (RECIST1. 1) and assess the prognostic …

Abstract Background Performing Response Evaluation Criteria in Solid Tumor (RECISTS)
measurement is a non-trivial task requiring much expertise and time. A deep learning-based …

Background To date, no study has been performed analyzing changes in the vascular
system comparing paired examinations of patients alive and after death with the use of …

Methods: In our study, renal volume was estimated on computerized tomographic renal
angiography images using Siemens volumetry software by drawing contours manually on …

Постановка проблемы. Жидкостная биопсия является современным методом анализа
дериватов опухоли, таких как экзосомальная и циркулирующая опухолевая ДНК …